MedPath

BEFRIENDAS study: The impact of befriending on depression, anxiety, social support and loneliness in older adults living in residential aged care facilities

Not Applicable
Recruiting
Conditions
Depression
Anxiety
Loneliness
Lack of social support
Mental Health - Depression
Mental Health - Anxiety
Registration Number
ACTRN12619000676112
Lead Sponsor
ational Ageing Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
544
Inclusion Criteria

Initial Eligibility criteria
1. Cornell Scale for Depression in Dementia (CSDD) score of 8 or greater as assessed by RACF staff (no longer than six months prior). The CSDD is routinely used in RACFs as part of funding reliability assessments and has been found to be a valid and reliable tool (Korner et al, 2006) or
2. Psychogeriatric Assessment Scale – Cognitive Impairment Scale (PAS-CIS; Jorm & Mackinnon, 1995) score equal to or less than 10, as assessed by RACF staff (no longer than six months prior) or
3. Clinical judgement of clinical care manager indicating significant depression or anxiety
symptoms, confirmed in further screening.
Further Eligibility screen
1. Geriatric Depression Scale (GDS;15 item version; Li et al, 2015) score of 4 or greater as assessed by the research team.
2. General Practitioner Assessment of Cognition (GPCOG; Brodaty et al, 2002) score of 4 or greater as assessed by the research assistants.

Exclusion Criteria

Exclusion criteria for residents:
-inability to give informed consent or understand English;
-PAS-CIS score greater than 10 (indicating moderate or severe cognitive impairment);
-progressive, unstable medical or neurological illness.
-under 65 years (Participants will be over 65 in line with the aims of the funding call).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression as measured by the 15 item Geriatric Depression Scale[Baseline (T1), 2 months (T2) and 4 months (T3 - primary endpoint) after the commencement of the intervention]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath